Purpose There are no comprehensive guidelines for the use of FDG PET in the following
three clinical scenarios:(1) diagnostic work-up of patients with idiopathic Parkinson's …

Accurate differential diagnosis of parkinsonism is of paramount therapeutic and prognostic
importance. In addition, with the development of invasive therapies and novel disease …

Purpose Dopamine transporter (DAT) imaging can demonstrate presynaptic dopaminergic
neuronal loss in Parkinson's disease (PD). However, differentiating atypical parkinsonism …

Parkinson disease (PD) is the second most common age-related neurodegenerative
disorder, affecting 1 to 2 million individuals in North America. Given that the incidence of PD …

Dementia is a frequent and devastating non-motor complication of advanced Parkinson's
disease (PD). There is growing evidence of a synergistic role of Alzheimer's-type brain …

Abstract Purpose Diagnosis of Parkinson's disease (PD) can be difficult. F-DOPA PET is
able to quantify striatal dopa decarboxylase activity and storage capacity of F-dopamine, but …

Aim To assess the clinical utility of FDG-PET as a diagnostic aid for differentiating
Alzheimer's disease (AD; both typical and atypical forms), dementia with Lewy bodies (DLB) …

Rationale Dopamine transporter (DAT) imaging is an important adjunct in the diagnostic
workup of patients with Parkinsonism. 18 F-FE-PE2I is a suitable PET radioligand for DAT …

Aim The aims in this study were to evaluate the role of brain 18 F-FDG PET imaging in
differential diagnosis of parkinsonism and to correlate brain metabolism findings with …

Parkinson's disease (PD) consists of loss of pigmented dopamine-secreting neurons in the
pars compacta of the midbrain substantia nigra. These neurons project to the striatum …